- Professor of Medicine and of Epidemiology and Biostatistics and of Biochemistry and Molecular Biology | Director of the Division of Renal Disease and Hypertension
- Cardiovascular Disease in Patients with Renal Diseases (Cardio-Renal Syndrome)
- Diabetic Renal Diseases
- Resistant Hypertension
- Cardiorenal syndrome
- Diabetic Kidney Disease
- MBBS - Madurai Medical College, 1982; MD - Stanley Medical College, 1988
- Medicine residency at Louisiana State Health Sciences Center
- Nephrology fellowship at University of Toronto, Canada and at Louisiana State Health Sciences Center
Dominic Raj, MD, DM, FASN is board-certified in Internal Medicine and Nephrology. He is a Professor of Medicine, Biochemistry & Genetics and Biostatistics and Epidemiology. He is the Director of the Division of Renal Diseases and Hypertension at the George Washington University School of Medicine and Health Sciences.
Dr. Raj is a Fellow of the American College of Physicians and a Fellow of the American Society of Nephrology. He has received a number of awards and recognition from various national and international institutions including the Distinguished Researcher Award from GW in 2014.
During his tenure at the George Washington University, Dr. Raj expanded the research portfolio, added new clinical services and revamped the educational program. He established a number of sub-specialty clinics such as the glomerular diseases clinic, kidney stone clinic, Polycystic Kidney Disease clinic, Kidney Wellness Clinic and ultrasound clinic. He is pivotal to establishing the kidney transplant program at GW. In order to serve the community needs, he established satellite practices in Maryland and Virginia. He has been named Washington Top Doctor multiple times. During his tenure, the Division of renal Diseases and Hypertension has been named “high performing” specialty by the US and World Report.
Dr. Raj has been invited as a visiting professor to a number of prestigious institutions including Harvard Medical School, Cornell University and New York University. He has chaired and spoken in multiple symposia organized by the American Society of Nephrology, International Society of Nephrology, German Society of Nephrology and European Association for the Study of Diabetes.
- TarGut ESRD study: Examines the effect of prebiotic therapy on gut microbiome and metabolome in Hemodialysis patients
- TarGut CKD study: Examines the effect of prebiotic therapy on gut microbiome and metabolome in patients with chronic kidney disease
- The Systolic Blood Pressure Intervention Trial-Alzheimer’s, Seniors, and Kidney Study (SPRINT ASK)
- Systolic Blood Pressure Intervention Trial Electronic Health Study (SPRINT-EHR)
- Cardiac Arrhythmia Monitoring and Related Outcomes in Dialysis Patients (CAMARO)
- Anti-Cytokine Therapy for Hemodialysis InflammatION (ACTION)
- An observational study to determine the immunopathophysiology of Diabetic Kidney Disease
- IL-6 pathway genes associated renal, cardiovascular and hematological phenotypes in CKD: Findings from the CRIC study
- The effects of Patiromer on serum potassium level and gut microbiome of ESRD patients with hyperkalemia
- A randomized, double-blind, placebo-controlled, phase 2 study to evaluate the safety and efficacy of IW-1973 in patients with type 2 diabetes with albuminuria treated with renin-angiotensin system inhibitors
- A phase 2 randomized, double blind, placebo-controlled trial to evaluate reduction in inflammation in patients with advance chronic renal disease utilizing antibody mediated IL-6 inhibition